Michael Vasconcelles has been named the chief medical officer of Cambridge, MA-based cellular immunotherapy startup Unum Therapeutics. Vasconcelles was previously the head of oncology at Takeda Pharmaceuticals. Unum, meanwhile, raised a $65 million Series B round in June to lay the foundation for a future IPO.
From Our Editors · Podcast
The AI, Big Data, and R&D Boom
Sponsored · Whitepaper
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson
Xconomy Insight · Special Report
Industry experts explain what it takes to launch a new biotech company
